Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | FRES |
---|---|---|
09:32 ET | 149 | 0.5963 |
09:34 ET | 2000 | 0.5787 |
09:36 ET | 3100 | 0.5444 |
09:38 ET | 4512 | 0.514 |
09:39 ET | 100 | 0.5103 |
09:41 ET | 500 | 0.5103 |
09:43 ET | 536 | 0.5011 |
09:45 ET | 1947 | 0.502 |
09:56 ET | 1000 | 0.5145 |
10:06 ET | 100 | 0.5144 |
10:14 ET | 500 | 0.5701 |
10:24 ET | 100 | 0.584447 |
10:26 ET | 700 | 0.5693 |
10:35 ET | 7356 | 0.5547 |
10:51 ET | 100 | 0.5547 |
10:53 ET | 950 | 0.5177 |
11:06 ET | 200 | 0.5434 |
11:26 ET | 200 | 0.54 |
11:31 ET | 1200 | 0.54 |
11:40 ET | 3400 | 0.5363 |
12:03 ET | 167 | 0.5363 |
12:12 ET | 100 | 0.52 |
12:18 ET | 987 | 0.5145 |
12:23 ET | 1225 | 0.5152 |
12:27 ET | 4812 | 0.5151 |
12:38 ET | 982 | 0.5493 |
01:19 ET | 735 | 0.5493 |
01:24 ET | 167 | 0.5493 |
02:06 ET | 100 | 0.5493 |
02:09 ET | 455 | 0.5493 |
02:54 ET | 167 | 0.5493 |
03:05 ET | 2000 | 0.5144 |
03:14 ET | 1000 | 0.5145 |
03:48 ET | 841 | 0.5144 |
03:52 ET | 1000 | 0.51 |
03:54 ET | 100 | 0.5022 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Fresh2 Group Ltd | 16.4M | -0.1x | --- |
Hi-Great Group Holding Co | 1.8M | 148.3x | --- |
Regen BioPharma Inc | 2.9M | -2.0x | --- |
Aclarion Inc | 2.1M | 0.0x | --- |
Mosaic Immunoengineering Inc | 2.3M | -2.2x | --- |
CNS Pharmaceuticals Inc | 2.3M | 0.0x | --- |
AnPac Bio-Medical Science Co Ltd is a China-based biotechnology company focused on early cancer screening and detection. The Company markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The Company have established two clinical laboratories in China and one clinical laboratory in the United States. The Company is also engaged in providing technical solution and outsourcing consulting service focusing on the digital, internet, and Web3 transformation of start-ups and traditional enterprises.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.4M |
---|---|
Revenue (TTM) | $1.6M |
Shares Outstanding | 32.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.46 |
EPS | $-4.04 |
Book Value | $-0.54 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 10.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -825.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.